Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.Who should not take VENCLEXTA?Ĭertain medicines must not be taken when you first start taking VENCLEXTA and while your dose is being slowly increased because of the risk of increased TLS. When restarting VENCLEXTA after stopping for 1 week or longer, your healthcare provider may again check for your risk of TLS and change your dose. Your healthcare provider may delay, decrease your dose, or stop treatment with VENCLEXTA if you have side effects. Drink 6 to 8 glasses (about 56 ounces total) of water each day, starting 2 days before your first dose, on the day of your first dose of VENCLEXTA, and each time your dose is increased. Tell your healthcare provider right away if you have any symptoms of TLS during treatment with VENCLEXTA, including fever, chills, nausea, vomiting, confusion, shortness of breath, seizures, irregular heartbeat, dark or cloudy urine, unusual tiredness, or muscle or joint pain.ĭrink plenty of water during treatment with VENCLEXTA to help reduce your risk of getting TLS. It is important to keep your appointments for blood tests. Your healthcare provider will do blood tests to check for TLS when you first start treatment and during treatment with VENCLEXTA.
You may also need to receive intravenous (IV) fluids into your vein. You will receive other medicines before starting and during treatment with VENCLEXTA to help reduce your risk of TLS. Your healthcare provider will do tests to check your risk of getting TLS before you start taking VENCLEXTA. TLS can cause kidney failure, the need for dialysis treatment, and may lead to death. TLS is caused by the fast breakdown of cancer cells. VENCLEXTA can cause serious side effects, including: Important Safety Information What is the most important information I should know about VENCLEXTA? After reaching the maximum program benefit, the patient will be responsible for all remaining out-of-pocket costs. Under the program, the patient will pay a co-pay. Patients using Medicare, Medicaid, or any other federal or state government program to pay for their medications are not eligible. *This Genentech Oncology Co-pay Assistance Program is valid ONLY for patients with commercial insurance who have a valid prescription for a Food and Drug Administration (FDA)-approved indication of a Genentech medication. The program covers the rest, up to a $25,000 per product limit per 12 months. You pay as little as $5 per prescription for VENCLEXTA + GAZYVA or VENCLEXTA + rituximab if you qualify for the Genentech OncologyĬo-pay Assistance Program. The Genentech Oncology Co-pay Assistance Program* for VENCLEXTA can help you with the out-of-pocket costs for your VENCLEXTA, GAZYVA® (obinutuzumab), or rituximab prescriptions, if you’re eligible. Genentech Oncology Co-pay Assistance Program for VENCLEXTA
0 kommentar(er)
